Novavax (NVAX) shares are falling after JPMorgan downgrades the stock to Underweight from Neutral. Shares have surged 250% since May after the company announced a strategic partnership with Sanofi (SNY).
Market Domination hosts Josh Lipton and Julie Hyman discuss the factors behind the call.
For more expert insights and the latest market activity, click here to watch the full episode of Market Domination.
This article was written by Gabriel Roy
